Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index; 12 of the 63 sources its claims cite were checked for support.
Abstract
The oral poliovaccine, a live vaccine made of attenuated poliovirus strains, is the main tool of the vaccination campaigns organised for eradicating poliomyelitis. these campaigns had led to the decline and, thereafter, to the disappearance of wild poliovirus strains of the three serotypes (1-3) in most parts of the world. However, when the poliovaccine coverage becomes too low, vaccine polioviruses can circulate in insufficiently immunized populations and become then pathogenic by mutations and genetic recombination with other enteroviruses of the same species, in particular some coxsackievirus A. These mutated and recombinant vaccine strains have been implicated in several epidemics of paralytic poliomyelitis. Two polio outbreaks associated with these pathogenic circulating vaccine-derived poliovirus (cVDPV) occurred in 2001-2002 and 2005 in the South of Madagascar where vaccine coverage was low. These cVDPV, of serotype 2 or 3, were isolated from paralyzed children and some of their healthy contacts. Other cVDPV were isolated in the same region from healthy children in 2011, indicating that these viruses were circulating again. Vaccination campaigns could stop the outbreaks in 2002 and 2005, and most probably prevent another one in 2011. Therefore, the genetic plasticity of poliovaccine strains that threatens the benefit of vaccination campaigns is the target of an accurate surveillance and an important theme of studies in the virology laboratories of the Institut Pasteur international network.
Overview
CoChat Summary
TL;DR
This review explains how oral polio vaccine campaigns have driven wild poliovirus toward eradication while also creating conditions for vaccine-derived polioviruses (cPVDV) to emerge when coverage is too low. It uses examples from Madagascar, Cameroon, and other countries to show that recombination with other HEV-C enteroviruses and weak vaccination coverage can produce neurovirulent, epidemic strains.
Key findings
- The WHO launched the poliomyelitis eradication programme in 1988, based on mass vaccination and acute flaccid paralysis surveillance; global cases fell by 99% by 2000, and the disease was “no longer endemic” in only three countries at the time of writing: Nigeria, Pakistan, and Afghanistan.
- In Madagascar, wild poliomyelitis disappeared in 1998, but 5 cPVDV-associated acute flaccid paralysis cases occurred between October 2001 and April 2002 in children aged 6 months to 11 years; community oral polio vaccine coverage ranged from 7% to 40%.
- In the same Madagascar setting, the authors report 7% of healthy children near the paralysed cases carried cPVDV; among healthy children tested for enteroviruses, 21% of stool samples were HEV-positive and 80% of those HEV were HEV-C.
- In Cameroon’s far north, nearly 37% of healthy children carried non-polio enteroviruses, and among positives more than 63% were HEV-C; the paper states this ecosystem resembled southern Madagascar and that cPVDV characterized there were recombinants between oral polio vaccine strains and other HEV-C.
Methods
- Narrative review/synthesis of prior surveillance, outbreak investigations, and virology studies from Madagascar, Cameroon, and other REIP countries, rather than a new prospective study.
- Draws on stool sampling and molecular characterization reported in the cited studies, including sequencing of the VP1 region and analysis of 5' and 3' genomic regions to assess mutation accumulation and recombination.
- Uses molecular-clock logic to infer circulation time from VP1 divergence, and compares genomic relationships between vaccine-derived polioviruses and co-circulating HEV-C enteroviruses.
Limitations
- The paper does not report a single original study design, sample size, or statistical analysis for this article itself; it synthesizes findings from previously published studies.
- The authors state that the molecular mechanisms leading to formation of recombinant cPVDV “remain to be elucidated.”
- Evident from the text: several country-level observations are based on selected regions and cited studies, so the conclusions about ecosystems and recombination are suggestive rather than presented as a controlled, generalizable test.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 47 Not checked · 52 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Dans les pays où la couverture vaccinale n'est pas optimale, une autre conséquence de l'instabilité génétique des souches du VPO est l'émergence de souches circulantes de PV dérivées du vaccin (cPVDV) [6].”
What the sources say
- Supportedcites [6] Kew, 2005, Annu Rev Microbiol source
The Abstract describes oral polio vaccine as genetically unstable and identifies outbreaks involving circulating vaccine-derived polioviruses in areas with low OPV coverage. The “Risk Factors for cVDPV Emergence and Spread” section likewise identifies insufficient population immunity and low vaccine coverage as conditions favoring their emergence and spread. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Des cPVDV, tous de type 2, ont été isolés chez les cinq enfants.”
What the sources say
- Supportedcites [12] Rousset, 2003, Emerg Infect Dis source
The paper reports five children with cases associated with type 2 vaccine-derived poliovirus isolates. It also states that nine type 2 poliovirus strains were isolated and that vaccine-derived poliovirus circulated in Madagascar (main text; page not specified). (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“les épidémies de cPVDV sont arrêtées par des campagnes de vaccination avec le VPO [6, 15].”
What the sources say
- Supportedcites [6] Kew, 2005, Annu Rev Microbiol source
The “Pre- and Posteradication Challenges” section states that poliovirus outbreaks can be controlled by mass immunization campaigns using OPV. The “cVDPVs from Polio Outbreaks” section also reports that the Hispaniola cVDPV outbreak stopped after mass OPV administration. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Partly supportedcites [15] Joffret, 2012, J Infect Dis sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports no additional polio cases after immunization campaigns responding to the 2005 Madagascar outbreak and suggests that population immunity was sufficient to eradicate the circulating VDPVs. The paper does not specify that those response campaigns used OPV, and its cautious account of one outbreak does not establish that OPV campaigns stop cVDPV epidemics generally. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Nos études in vitro ont confirmé que ces virus sont des partenaires de recombinaison compatibles [18].”
What the sources say
- Partly supportedcites [18] Jegouic, 2009, PLoS Pathog sourceExperimental — accuracy not yet measured
The section on molecular cloning and chimeric viruses reports that PV–CA17 constructs produced viable viruses in vitro, supporting CA17 as a compatible recombination partner. The Discussion describes a possible role for CA13 based on genetic relationships, but does not report an in vitro confirmation that CA13 is a compatible PV recombination partner. No page numbers are available in our copy. (LLM, conf=0.88)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“les déterminants majeurs de l'atténuation des souches vaccinales Sabin, qui se trouvent dans la région 5' non codante et affectent l'efficacité de la traduction, ont subi, chez les cPVDV, des réversions vers le génotype sauvage [13, 15, 20].”
What the sources say
- Partly supportedcites [13] Rakoto-Andrianarivelo, 2007, PLoS Pathog sourceExperimental — accuracy not yet measured
The Introduction (p.1) supports only the generic half of the claim: 'replication of OPV in humans is frequently accompanied by genetic changes in the vaccine virus. The changes can include reversion of key attenuating mutations and acquisition of other mutations throughout the genome' — a hedged statement, not a demonstration that the major attenuation determinants reverted to wild genotype in circulating VDPVs. Nothing in our copy localizes those determinants to the 5' non-coding region or links them to translation efficiency (searched: 5' UTR/attenuation determinant, translation efficiency/IRES, nucleotide 480). On the contrary, the Results ('Sequence Analysis of the Madagascan VDPV Genomes') show the 5'-halves remained Sabin 2-derived with differences at few positions and place the recombination junctions in protease 2A (nt ~3,708–3,801), while 'Phenotypic Characteristics' says only that some vaccine-part substitutions 'may have affected the phenotype of the vaccine strain Sabin 2'. The 5'-NCR/translation-efficiency mechanism attributed to this source is therefore not supported by it. (LLM, conf=0.70)
- Partly supportedcites [15] Joffret, 2012, J Infect Dis sourceExperimental — accuracy not yet measured
The paper's own sequencing results (Analysis of the Sequences of the VDPV Genomes From Madagascar) state that vaccine-derived genomic regions in the cVDPVs 'systematically displayed mutations affecting the major attenuation determinants of the OPV strains, at position A481G in the 5' UTR and at Ile143Thr of VP1 for VDPV2 and T472C in the 5' UTR and Phe91Ser of VP3 for VDPV3', so the change in the 5' UTR attenuation determinants of circulating VDPVs is supported. However, our copy nowhere describes these determinants as acting on translation efficiency — that genetic-basis point is credited to other works it cites (references 22–25: Macadam et al. 1989/1993, Ren et al. 1991, Westrop et al. 1989) — and it characterises the changes as 'mutations', not as reversions to the wild-type genotype; indeed for VDPV2 the 5' UTR is reported as derived from nonpoliovirus (CAV13-related) sequences rather than wild-type poliovirus. The claim's mechanistic and 'reversion vers le génotype sauvage' elements therefore go beyond what this source says. (LLM, conf=0.78)
- Supportedcites [20] Combelas, 2011, Viruses source
In the section "Genetic Features of Recombinant cVDPV Genomes", our copy states that when sequenced, all major attenuation determinants located in the 5′NC OPV genomic regions and known to affect the efficiency of genomic translation were found to have reverted to wild-type nt (at positions 480, 481 and 472 of Sabin 1, 2 and 3). The Introduction ("Poliovirus and Poliomyelitis: Successes and Recent Hurdles in Eradication") independently confirms that the major attenuation determinants of the three OPV strains lie in the 5′NC region and affect IRES/genomic translation efficiency. Together these state every element of the attributed paraphrase, including the cVDPV population. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
57 more claims · 1 with their cited sources checked
Create a free account to see all 107 claims and to verify the 51 references still open.
- It may state two separate claims as one. 40
- Probably not a substantial claim. 14
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These cVDPVs have acquired the important biological properties of the WPV, namely efficient transmission from person to person and the ability to cause severe paralysis [90].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [90]
Citations
Cites
Enteroviruses : Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses
Pallansch, M. (2001) · Medical Entomology and Zoology · Cited by 890
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · cited 2×
“Les deux premières ont été causées par des virus de type 1 sur l’île d’Hispaniola (à Saint Domingue et Haïti) et aux Philippines [7, 8].”
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993
Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233
Burns, C. C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M. A., Abanida, E. A., Gasasira, A., Iber, J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02954-12 · Cited by 153
Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001
Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146
Recombinant Vaccine–Derived Poliovirus in Madagascar
Rousset, D., Rakoto-Andrianarivelo, M., Razafindratsimandresy, R., Randriamanalina, B., Guillot, S., Balanant, J., Mauclère, P., & Delpeyroux, F. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0907.020692 · Cited by 138 · cited 3×
“L’analyse de la région codant pour les protéines de capside dans la moitié 5’ du génome a montré que ces virus dérivaient de la souche Sabin 2 du VPO, et se partageaient en deux groupes selon leur lieu d’isolement [12, 13].”
BackgroundSelf-citationCombelas, N., Holmblat, B., Joffret, M.-L., Colbère-Garapin, F., & Delpeyroux, F. (2011) · Viruses · doi:10.3390/v3081460 · Cited by 135
Self-citationWassilak, S., Pate, M. A., Wannemuehler, K., Jenks, J., Burns, C., Chenoweth, P., Abanida, E. A., Adu, F., Baba, M., Gasasira, A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq140 · Cited by 120
Jegouic, S., Joffret, M.-L., Blanchard, C., Riquet, F. B., Perret, C., Pelletier, I., Colbere-Garapin, F., Rakoto-Andrianarivelo, M., & Delpeyroux, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000412 · Cited by 116
Self-citation
Research works printed but not linked: 3
- Anonymous, 2012, MMWR Morb Mortal Wkly Rep, 61, 741
- Blondel, 2008, Med Trop, 68, 189
- Haddad-Boubaker, 2007, Arch Inst Pasteur Tunis, 84, 3
Cited by
Simonyan, V. V., Chumakov, K., Dingerdissen, H., Faison, W. J., Goldweber, S., Golikov, A., Gulzar, N., Karagiannis, K., Lam, P. V. N., Maudru, T., et al. (2016) · Database · doi:10.1093/database/baw022 · Cited by 78
Arbovirosis and potential transmission blocking vaccines
Londono-Renteria, B. L., Troupin, A., & Colpitts, T. M. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1802-0 · Cited by 59
The Fight against Poliovirus Is Not Over
Mbani, C. J., Nekoua, M. P., Moukassa, D., & Hober, D. (2023) · Microorganisms · doi:10.3390/microorganisms11051323 · Cited by 34
“These cVDPVs have acquired the important biological properties of the WPV, namely efficient transmission from person to person and the ability to cause severe paralysis [90].”
BackgroundLizasoain, A., Burlandy, F. M., Victoria, M., Tort, L. F. L., da Silva, E. E., & Colina, R. (2018) · Food and Environmental Virology · doi:10.1007/s12560-018-9351-7 · Cited by 10
Razavi, S. M., Mardani, M., & Salamati, P. (2016) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.36867 · Cited by 8
Metadata
- Authors
- Delpeyroux, F., Colbère-Garapin, F., Razafindratsimandresy, R., Sadeuh-Mba, S., Joffret, M.-L., Rousset, D., & Blondel, B.
- Affiliations
- Inserm (FR)
- Institut Pasteur de Madagascar (MG)
- Institut Pasteur de la Guyane (GF)
- Venue
- médecine/sciences
- Publisher
- EDP Sciences
- Published
- 2013-11
- Volume
- 29
- Issue
- 11
- Pages
- 1034-1041
- ISSN
- 0767-0974 (ISSN-L)
- 1958-5381
- OpenAlex
- W2146889643
- Cited by
- 11
- References
- 28
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 3 · 2014: 1
- FWCI
- 0.91
- Type
- journal article
- Language
- fr
- Open access
- bronze
- doi.org
- Locations
- médecine/sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- polio eradication, circulating vaccine-derived poliovirus, attenuated poliovirus, genetic recombination, coxsackievirus A, low vaccination coverage, Madagascar, polio surveillance, genome plasticity
- MeSH terms
- Cameroon, Disease Outbreaks, Enterovirus, Humans, Madagascar, Mutation, Poliomyelitis, Poliovirus Vaccine, Oral, Recombination, Genetic, Poliovirus, Mass Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun. https://app.cochat.ai/papers/10.1051/medsci/20132911021
- The paper
- Delpeyroux, F., Colbère-Garapin, F., Razafindratsimandresy, R., Sadeuh-Mba, S., Joffret, M.-L., Rousset, D., & Blondel, B. (2013). Éradication de la poliomyélite et émergence de poliovirus pathogènes dérivés du vaccin: De Madagascar au Cameroun. médecine/sciences. https://doi.org/10.1051/medsci/20132911021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.